COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,189 Articles (22,713 medRxiv, 8,476 bioRxiv)

Most recent first Previous |  Page 1364: Articles 13631-13640  | Next

Collaboration Between Host and Viral Factors Shape SARS-CoV-2 Evolution
Bamford, C. G. G., Broadbent, L., Aranday Cortes, E., McCabe, M., McKenna, J., Courtney, D., Touzelet, O., Ali, A., Roberts, G., Lopez Campos, G., Simpson, D., McCaughey, C., Fairley, D., Mills, K., Power, U. F., The Breathing Together Consortium
10.1101/2021.07.16.452629 — Posted: 2021-07-16
Adoption and continued use of mobile contact tracing technology: Multilevel explanations from a three-wave panel survey and linked data
Horvath, L., Banducci, S., Blamire, J., Degnen, C., James, O., Jones, A., Stevens, D., Tyler, K.
10.1101/2021.07.13.21260444 — Posted: 2021-07-16
Acute phase clinical manifestation of COVID-19 is linked to long-COVID symptoms; A 9-month follow-up study
Mirfazeli, F., Sarabi-Jamab, A., kordi, A., Shariati, B., Shariat, S. V., Bahrami, S., Nohesara, S., Almasi-Dooghaee, M., Faiz, S. H. R.
10.1101/2021.07.13.21260482 — Posted: 2021-07-16
Social risk factors for SARS-CoV-2 acquisition in University students: cross sectional survey
Blakey, E., Reeve, L., Verlander, N. Q., Edwards, D. E., Wyllie, D., Reacher, M.
10.1101/2021.07.15.21260006 — Posted: 2021-07-16
Patterns of SARS-CoV-2 exposure and mortality suggest endemic infections, in addition to space and population factors, shape dynamics across countries
Fountain-Jones, N. M., Yates, L., Flies, E., Flies, A., Carver, S., Charleston, M.
10.1101/2021.07.12.21260394 — Posted: 2021-07-16
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Lopez-Jaime, F. J., Martin-Tellez, S., Doblas-Marquez, A., Marquez-Gomez, I., Reguera-Iglesias, J. M., Munoz-Perez, M. I., Fernandez-Bello, I., Montano, A.
10.1101/2021.07.13.21260256 — Posted: 2021-07-16
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection
Haveri, A., Ekström, N., Solastie, A., Virta, C., Österlund, P., Isosaari, E., Nohynek, H., Palmu, A. A., Melin, M.
10.1101/2021.07.13.21260426 — Posted: 2021-07-16
Rapid and Quantitative Detection of Human Antibodies Against the 2019 Novel Coronavirus SARS CoV2 and its Variants as a Result of Vaccination and Infection
Taubner, B., Peredo-Wende, R., Ramani, A., Singh, G., Strle, K., Cady, N.
10.1101/2021.07.13.21260442 — Posted: 2021-07-16
Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2
V, J. K., Sowpati, D. T., Munigela, A., Banu, S., Siva, A. B., Sasikala, M., Nutalapati, C., Kulkarni, A., Mukherjee, P., Zaveri, L., CCMB COVID-19 Team, , AIG Hospitals COVID-19 Vaccine study Team, , Tallapaka, K. B., D, N. R.
10.1101/2021.07.13.21260417 — Posted: 2021-07-16
Monitoring of COVID-19 Pandemic-related Psychopathology using Machine Learning
Enevoldsen, K. C., Danielsen, A., Rohde, C., Jefsen, O. H., Nielbo, K., Ostergaard, S. D.
10.1101/2021.07.13.21259962 — Posted: 2021-07-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).